Integrated Cancer Repository for Cancer Research (NCT02012699) | Clinical Trial Compass
RecruitingNot Applicable
Integrated Cancer Repository for Cancer Research
United States999,999 participantsStarted 2013-11-01
Plain-language summary
The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rural hospitals and cancer centers. The iCaRe2 advances comprehensive studies of risk factors of cancer development and progression and enables the design of novel strategies for prevention, screening, early detection and personalized treatment of cancer. Centers with expertise in cancer epidemiology, genetics, biology, early detection, and patient care can collaborate by using the iCaRe2 as a platform for cohort and population studies.
Who can participate
Age range
19 Years – 110 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
* Diagnosis/history of cancer
* Risk for developing cancer or suspicious clinical findings
* No history of cancer (normal control registry)
* Able to provide informed consent
* 19 years of age or older
* English or Spanish speaking individuals
Exclusion Criteria
* Unable to provide informed consent because of cognitive impairment
* Non-English or non-Spanish speaking individuals
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial seems to be a registry study that collects data rather than testing a treatment — does that mean participating wouldn't change my actual cancer care or treatment plan in any way?
2Since this is a data and tissue repository rather than a clinical trial testing a new therapy, what exactly would I be asked to contribute — things like blood samples, tissue, medical records — and how often would I need to come in?
3My specific cancer type is listed among dozens of conditions in this registry, so how would my information actually be used, and would I ever have access to any findings that come from it?
4Are there any privacy or data-sharing considerations I should be aware of before agreeing to have my medical and biological information stored in a web-based collaborative registry?
5Given that this is a registry and not a treatment study, is there any reason you'd recommend I look into an active treatment trial alongside or instead of joining this one?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Development and Implementation of a Web-based Cancer Collaborative Registry